Pro Share Advisors LLC Medpace Holdings, Inc. Transaction History

Pro Share Advisors LLC

  • $48.7 Billion
  • Q2 2025

A detailed history of Pro Share Advisors LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 2,188 shares of MEDP stock, worth $1.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,188
Previous 2,482 11.85%
Holding current value
$1.15 Million
Previous $756,000 9.26%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025
SELL
$277.23 - $315.28 $81,505 - $92,692
-294 Reduced 11.85%
2,188 $686,000
Q1 2025

May 08, 2025
SELL
$304.69 - $360.97 $68,859 - $81,579
-226 Reduced 8.35%
2,482 $756,000
Q4 2024

Feb 13, 2025
SELL
$308.93 - $363.58 $85,882 - $101,075
-278 Reduced 9.31%
2,708 $899,000
Q3 2024

Nov 13, 2024
SELL
$320.58 - $457.29 $26,287 - $37,497
-82 Reduced 2.67%
2,986 $995,000
Q2 2024

Aug 13, 2024
SELL
$372.0 - $424.34 $100,068 - $114,147
-269 Reduced 8.06%
3,068 $1.26 Million
Q1 2024

May 08, 2024
BUY
$284.87 - $413.31 $28,771 - $41,744
101 Added 3.12%
3,337 $1.35 Million
Q4 2023

Feb 14, 2024
SELL
$227.52 - $312.68 $12,286 - $16,884
-54 Reduced 1.64%
3,236 $991,000
Q3 2023

Nov 13, 2023
SELL
$233.98 - $281.67 $39,542 - $47,602
-169 Reduced 4.89%
3,290 $796,000
Q2 2023

Aug 10, 2023
SELL
$187.26 - $240.17 $612,527 - $785,596
-3,271 Reduced 48.6%
3,459 $830,000
Q1 2023

May 11, 2023
SELL
$174.31 - $239.52 $181,456 - $249,340
-1,041 Reduced 13.4%
6,730 $1.27 Million
Q4 2022

Feb 02, 2023
BUY
$153.06 - $226.57 $91,223 - $135,035
596 Added 8.31%
7,771 $1.65 Million
Q3 2022

Nov 04, 2022
SELL
$145.13 - $182.49 $67,050 - $84,310
-462 Reduced 6.05%
7,175 $1.13 Million
Q2 2022

Aug 01, 2022
SELL
$130.2 - $168.03 $560,641 - $723,537
-4,306 Reduced 36.05%
7,637 $1.14 Million
Q1 2022

May 10, 2022
SELL
$138.87 - $214.31 $385,225 - $594,495
-2,774 Reduced 18.85%
11,943 $1.95 Million
Q4 2021

Feb 08, 2022
BUY
$182.74 - $227.9 $126,638 - $157,934
693 Added 4.94%
14,717 $3.2 Million
Q3 2021

Nov 12, 2021
SELL
$170.18 - $198.21 $349,549 - $407,123
-2,054 Reduced 12.78%
14,024 $2.65 Million
Q2 2021

Aug 13, 2021
BUY
$158.62 - $194.3 $259,819 - $318,263
1,638 Added 11.34%
16,078 $2.84 Million
Q1 2021

May 14, 2021
BUY
$132.02 - $168.26 $85,680 - $109,200
649 Added 4.71%
14,440 $2.37 Million
Q4 2020

Feb 09, 2021
BUY
$109.38 - $149.19 $316,655 - $431,905
2,895 Added 26.57%
13,791 $1.92 Million
Q3 2020

Nov 13, 2020
BUY
$92.95 - $130.61 $100,757 - $141,581
1,084 Added 11.05%
10,896 $1.22 Million
Q2 2020

Aug 03, 2020
BUY
$68.08 - $95.68 $189,875 - $266,851
2,789 Added 39.71%
9,812 $913,000
Q1 2020

May 15, 2020
SELL
$61.71 - $101.95 $324,718 - $536,460
-5,262 Reduced 42.83%
7,023 $515,000
Q4 2019

Feb 12, 2020
SELL
$70.08 - $84.64 $88,511 - $106,900
-1,263 Reduced 9.32%
12,285 $1.03 Million
Q3 2019

Nov 12, 2019
BUY
$62.38 - $85.89 $2,557 - $3,521
41 Added 0.3%
13,548 $1.14 Million
Q2 2019

Aug 13, 2019
SELL
$53.64 - $65.42 $92,743 - $113,111
-1,729 Reduced 11.35%
13,507 $884,000
Q1 2019

May 15, 2019
BUY
$49.38 - $70.58 $43,256 - $61,828
876 Added 6.1%
15,236 $898,000
Q4 2018

Feb 14, 2019
SELL
$46.97 - $63.98 $131,703 - $179,399
-2,804 Reduced 16.34%
14,360 $760,000
Q3 2018

Nov 14, 2018
BUY
$43.25 - $63.74 $29,150 - $42,960
674 Added 4.09%
17,164 $1.03 Million
Q2 2018

Aug 13, 2018
SELL
$34.03 - $45.46 $38,147 - $50,960
-1,121 Reduced 6.37%
16,490 $709,000
Q1 2018

May 14, 2018
SELL
$32.03 - $39.05 $117,197 - $142,883
-3,659 Reduced 17.2%
17,611 $615,000
Q4 2017

Feb 14, 2018
BUY
$32.46 - $38.31 $690,424 - $814,853
21,270
21,270 $771,000

Others Institutions Holding MEDP

# of Institutions
651
Shares Held
26.9M
Call Options Held
54.2K
Put Options Held
108K
View Full List

About Medpace Holdings, Inc.

MEDP Quotes by TradingView
  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $16.4B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email